Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 0

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Self-reported sleep disturbances during chemotherapy mediate circulating IL-1β effects on subjective cognitive decline in breast cancer patients

Tapp, Zoe M., Beales, Jeremy T., Yiadom, Seth Adarkwah, Sardesai, Sagar D., Williams, Nicole O., Gatti-Mays, Margaret E., Stover, Daniel G., Sudheendra, Preeti K., Dawson, Erica, Wesolowski, Robert, Andridge, Rebecca R., Pyter, Leah M.·2027·Brain, Behavior, and Immunity
DOI 10.1016/j.bbi.2026.107089
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2026.107089

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 86

  1. Arditte Hall, 2024, An exploration into the relationship between insomnia and repetitive negative thinking among cancer survivors, J. Psychosoc. Oncol., 43, 59, 10.1080/07347332.2024.2356193 · DOI · Paper page
  2. Ballestar-Tarín, 2023, Increased salivary IL-1 beta level is associated with poor sleep quality in university students, Diseases, 11, 136, 10.3390/diseases11040136 · DOI
  3. Bambrah, 2019, Anticipated, experienced, and remembered subjective effort and discomfort on sustained attention versus working memory tasks, Conscious. Cogn., 75, 10.1016/j.concog.2019.102812 · DOI
  4. Baron, 1986, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations, J. Pers. Soc. Psychol., 51, 1173, 10.1037/0022-3514.51.6.1173 · DOI · Paper page
  5. Bates, 2015, Fitting linear mixed-effects models using lme4, J. Stat. Softw., 67, 1, 10.18637/jss.v067.i01 · DOI · Paper page
  6. Beales, 2026, Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain, Brain Behav. Immun., 135, 10.1016/j.bbi.2026.106489 · DOI
  7. Behranvand, 2021, Chemotherapy: a double-edged sword in cancer treatment, Cancer Immunol. Immunother., 71, 507, 10.1007/s00262-021-03013-3 · DOI · Paper page
  8. Benedict, 1998, Hopkins verbal learning test - revised: Normative data and analysis of inter-form and test-retest reliability, Clin. Neuropsychol., 12, 43, 10.1076/clin.12.1.43.1726 · DOI · Paper page
  9. Bevans, 2014, Patient-Reported Outcomes Measurement Information System (PROMIS®): Efficient, Standardized Tools to measure Self-Reported Health and Quality of Life, Nurs. Outlook, 62, 339, 10.1016/j.outlook.2014.05.009 · DOI · Paper page
  10. Bock, 2025, Sleep quality and lymphedema in breast cancer survivors: a mixed method analysis, J. Cancer Surviv., 19, 978, 10.1007/s11764-023-01516-9 · DOI
  11. Boscher, 2020, Perceived Cognitive Impairment in Breast Cancer Survivors and its Relationships with Psychological Factors, Cancers, 12, 1
  12. Bower, 2021, Targeting depressive symptoms in younger breast cancer survivors: the pathways to wellness randomized controlled trial of mindfulness meditation and survivorship education, J. Clin. Oncol., 39, 3473, 10.1200/JCO.21.00279 · DOI · Paper page
  13. Bruner, 2011, Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for adverse events (PRO-CTCAE), Transl. Behav. Med., 1, 110, 10.1007/s13142-011-0025-3 · DOI
  14. Buysse, 2010, Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments, Sleep, 33, 781, 10.1093/sleep/33.6.781 · DOI · Paper page
  15. Chen, 2025, Investigating the relationship between sleep disturbances and cortical thickness, brainstem volume, amyloid accumulation, and inflammatory markers in Parkinson’s disease patients, Exp. Gerontol., 205, 10.1016/j.exger.2025.112762 · doi:10.1016/j.exger.2025.112762
  16. Cheung, 2015, Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study, Ann. Oncol., 26, 1446, 10.1093/annonc/mdv206 · DOI · Paper page
  17. Clevenger, 2012, Sleep disturbance, cytokines, and fatigue in women with ovarian cancer, Brain Behav. Immun., 26, 1037, 10.1016/j.bbi.2012.04.003 · DOI
  18. Clinton, 2011, Biochemical regulation of sleep and sleep biomarkers, J. Clin. Sleep Med., 7, 10.5664/JCSM.1360 · DOI · Paper page
  19. Cox, 2020, Sleep in the anxiety-related disorders: a meta-analysis of subjective and objective research, Sleep Med. Rev., 51, 10.1016/j.smrv.2020.101282 · DOI · Paper page
  20. Crouch, 2023, The Relationship between Self-reported Cognitive Abilities and Psychological Symptoms in Breast Cancer Survivors, Cancer Nurs., 46, 29, 10.1097/NCC.0000000000001073 · DOI
  21. del Águila, 2026, Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients, Psychoneuroendocrinology, 186, 10.1016/j.psyneuen.2026.107749 · DOI
  22. Duivon, 2022, Are sleep complaints Related to Cognitive Functioning in Non-Central nervous System Cancer?, A Systematic Review. Neuropsychol. Rev., 32, 483, 10.1007/s11065-021-09521-4 · DOI
  23. Durán-Gómez, 2023, Prevalence of Psychoneurological Symptoms and Symptom Clusters in Women with Breast Cancer Undergoing Treatment: Influence on Quality of Life, Semin. Oncol. Nurs., 39, 10.1016/j.soncn.2023.151451 · DOI
  24. Enderlin, 2011, Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer, Oncol. Nurs. Forum, 38, 10.1188/11.ONF.E314-E325 · DOI
  25. Escalante, 2009, Cancer-related fatigue: the approach and treatment, J. Gen. Intern. Med., 24, 412, 10.1007/s11606-009-1056-z · DOI
  26. Fisher, 2025, Insomnia and related symptom severity in women with breast cancer and pain receiving treatment in medically underserved areas, Behav. Sleep Med., 23, 834, 10.1080/15402002.2025.2542296 · DOI
  27. Friedman, 2021, The role of prefrontal cortex in cognitive control and executive function, Neuropsychopharmacology, 47, 72, 10.1038/s41386-021-01132-0 · DOI · Paper page
  28. Garland, 2025, Development of a mobile App (iCANSleep) to treat insomnia in cancer survivors: user-centered design study, JMIR Cancer, 11, 10.2196/74387 · DOI
  29. Garland, 2019, Integrative Approaches for sleep Health in Cancer Survivors, Cancer J., 25, 337, 10.1097/PPO.0000000000000398 · DOI
  30. Ghilotti, 2021, Relationship between sleep characteristics and markers of inflammation in Swedish women from the general population, J. Sleep Res., 30, 10.1111/jsr.13093 · DOI
  31. Ghiringhelli, 2009, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, Nat. Med., 15, 1170, 10.1038/nm.2028 · DOI · Paper page
  32. Goldberg, 2015, Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer’s disease randomized controlled trials, Alzheimer’s Dement. Diagn. Assessm. Dis. Monitor., 1, 103
  33. Gwenzi, 2024, Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts, ESMO Open, 9, 10.1016/j.esmoop.2024.102982 · doi:10.1016/j.esmoop.2024.102982
  34. Halemani, 2026, Global prevalence of anxiety, depression and stress in women with breast cancer: a systematic review and meta-analysis, J. Affect. Disord., 405, 10.1016/j.jad.2026.121541 · DOI
  35. Henneghan, 2023, Validating the PROMIS cognitive function short form in cancer survivors, Breast Cancer Res. Treat., 201, 139, 10.1007/s10549-023-06968-2 · DOI
  36. Huang, 2025, Associations between subjective sleep quality and inflammatory markers in patients with treatment-resistant depression, CNS Spectr., 30, e60, 10.1017/S1092852925000227 · DOI
  37. Hutchinson, 2012, Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review, Cancer Treat. Rev., 38, 926, 10.1016/j.ctrv.2012.05.002 · DOI · Paper page
  38. Irwin, 2017, Tai Chi Chih compared with cognitive behavioral therapy for the Treatment of Insomnia in Survivors of Breast Cancer: a randomized, partially blinded, noninferiority trial, J. Clin. Oncol., 35, 2656, 10.1200/JCO.2016.71.0285 · DOI · Paper page
  39. Irwin, 2019, Sleep and inflammation: partners in sickness and in health, Nat. Rev. Immunol., 19, 702, 10.1038/s41577-019-0190-z · DOI · Paper page
  40. Irwin, 2024, Tai Chi compared with cognitive behavioral therapy and the reversal of systemic, cellular and genomic markers of inflammation in breast cancer survivors with insomnia: a randomized clinical trial, Brain Behav. Immun., 120, 159, 10.1016/j.bbi.2024.05.022 · DOI
  41. Irwin, 2015, Sleep Disturbance, sleep Duration, and Inflammation: a Systematic Review and Meta-Analysis of Cohort Studies and Experimental sleep Deprivation, Biol. Psychiatry, 80, 40, 10.1016/j.biopsych.2015.05.014 · DOI · Paper page
  42. Iverson, 2021, Normative reference values, reliability, and item-level symptom endorsement for the PROMIS® v2.0 cognitive function-short forms, Clin. Neuropsychol., 36, 1341, 10.1093/arclin/acaa128 · DOI
  43. Kim, 2021, Determinants of the higher prevalence and severity of subjective cognitive impairment in cancer patients compared to healthy subjects: fatigue and stress, Clin. Nurs. Res., 30, 809, 10.1177/1054773820957474 · DOI
  44. Krueger, 2003, Humoral links between sleep and the immune system: Research issues, Ann. N. Y. Acad. Sci., 992, 9, 10.1111/j.1749-6632.2003.tb03133.x · DOI · Paper page
  45. Lee, 2020, Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for…, Journal of Patient-Reported Outcomes, 4, 106, 10.1186/s41687-020-00271-0 · DOI
  46. Lengacher, 2025, A randomized clinical trial of mindfulness-based stress reduction program among breast cancer survivors post-treatment: evaluating mediators of cognitive improvement, J. Integ. Complement. Med., 31, 367, 10.1089/jicm.2024.0493 · DOI
  47. Leung, 2016, Feasibility and diagnostic accuracy of the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for routine surveillance of sleep and fatigue problems in ambulatory cancer care, Cancer, 122, 2906, 10.1002/cncr.30134 · DOI
  48. Li, 2022, A psychological nursing intervention for patients with breast cancer on inflammatory factors, negative emotions and quality of life, Iran. J. Public Health, 51, 2041
  49. Liou, 2019, The Relationship between Insomnia and Cognitive Impairment in Breast Cancer Survivors, JNCI Cancer Spectr., 3, 10.1093/jncics/pkz041 · DOI · Paper page
  50. Lv, 2020, Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): an Updated Literature Review, J. Oncol., 2020, 10.1155/2020/3942439 · DOI
  51. Nowakowski, 2018, Sleep characteristics and inflammatory biomarkers among midlife women, Sleep, 41, 10.1093/sleep/zsy049 · DOI
  52. Oliva, 2024, Cognitive impairment following breast cancer treatments: an umbrella review, Oncologist, 29, e848, 10.1093/oncolo/oyae090 · DOI
  53. Ono, 2015, A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer, Front. Oncol., 5, 10.3389/fonc.2015.00059 · DOI
  54. Oppegaard, 2021, Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways, Cytokine, 148, 10.1016/j.cyto.2021.155653 · DOI
  55. Otto-Dobos, 2024, Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer, Brain Behav. Immun., 120, 208, 10.1016/j.bbi.2024.05.039 · DOI · Paper page
  56. Patel, 2026, Association between inflammatory biomarkers and depressive symptoms in breast cancer: a systematic review, Brain Behav. Immun., 136, 10.1016/j.bbi.2026.106594 · DOI
  57. Payne, 2008, Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy, Oncol. Nurs. Forum, 35, 635, 10.1188/08.ONF.635-642 · DOI · Paper page
  58. Pengo, 2018, Sleep in women across the life span, Chest, 154, 196, 10.1016/j.chest.2018.04.005 · DOI · Paper page
  59. Pomykala, 2013, The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer, Brain Imaging Behav., 7, 511, 10.1007/s11682-013-9243-2 · DOI
  60. Priede, 2022, Cognitive variables associated with depressive and anxiety symptoms in patients with cancer: a five-year follow-up study, Psychooncology, 31, 798, 10.1002/pon.5864 · DOI
  61. Pullens, 2010, Subjective cognitive dysfunction in breast cancer patients: a systematic review, Psychooncology, 19, 1127, 10.1002/pon.1673 · DOI · Paper page
  62. Rahman, 2014, Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans, Brain Behav. Immun., 47, 4, 10.1016/j.bbi.2014.11.003 · DOI
  63. Rothrock, 2020, Development and validation of an interpretive guide for PROMIS scores, J. Patient-Rep. Outcomes, 4, 16, 10.1186/s41687-020-0181-7 · DOI · Paper page
  64. Ryan, 2001, Wechsler adult intelligence scale-III, Understanding Psychological Assessment, 19–42, 10.1007/978-1-4615-1185-4_2 · DOI · Paper page
  65. Savard, 2011, Natural course of insomnia comorbid with cancer: an 18-month longitudinal study, J. Clin. Oncol., 29, 3580, 10.1200/JCO.2010.33.2247 · DOI · Paper page
  66. Schroyen, 2021, Neuroinflammation and its association with cognition, neuronal markers and peripheral inflammation after chemotherapy for breast cancer, Cancers (Basel), 13, 4198, 10.3390/cancers13164198 · DOI
  67. Schroyen, 2022, Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: a systematic review, Transl. Oncol., 16, 10.1016/j.tranon.2021.101297 · DOI
  68. Segawa, 2020, A comparison of computer adaptive tests (CATs) and short forms in terms of accuracy and number of items administrated using PROMIS profile, Qual. Life Res., 29, 213, 10.1007/s11136-019-02312-8 · DOI
  69. Siegel, 2025, Cancer statistics, 2025, CA Cancer J. Clin., 75, 10
  70. Sleurs, 2022, Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe, Crit. Rev. Oncol. Hematol., 180, 10.1016/j.critrevonc.2022.103859 · DOI
  71. Starkweather, 2017, Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer, Support Care Cancer, 25, 167
  72. Strollo, 2020, Cancer-related problems, sleep quality, and sleep disturbance among long-term cancer survivors at 9-years post diagnosis, Sleep Med., 65, 177, 10.1016/j.sleep.2019.10.008 · DOI
  73. Tingley, 2014, mediation: R Package for Causal Mediation Analysis, J. Stat. Softw., 59, 1, 10.18637/jss.v059.i05 · DOI · Paper page
  74. Tombaugh, 2004, Trail making test a and B: normative data stratified by age and education, Arch. Clin. Neuropsychol., 19, 203, 10.1016/S0887-6177(03)00039-8 · DOI · Paper page
  75. Tombaugh, 1999, Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming, Arch. Clin. Neuropsychol., 14, 167
  76. Tucker, 2021, Longitudinal changes in sleep: Associations with shifts in circulating cytokines and emotional distress in a cancer survivor population, Int. J. Behav. Med., 28, 140, 10.1007/s12529-020-09950-0 · DOI
  77. Van Der Willik, 2018, Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study, Breast Cancer Res., 20, 10.1186/s13058-018-1062-3 · DOI
  78. Vardy, 2007, Cognitive function after chemotherapy in adults with solid tumours, Crit. Rev. Oncol. Hematol., 63, 183, 10.1016/j.critrevonc.2007.06.001 · DOI · Paper page
  79. Vitali, 2017, Cognitive impairment and chemotherapy: a brief overview, Crit. Rev. Oncol. Hematol., 118, 7, 10.1016/j.critrevonc.2017.08.001 · DOI
  80. Wang, 2025, Psychological interventions and sleep improvement for patients with gastric cancer: effects on immune function, inflammation, and tumor progression—a randomized controlled trial, Ann. Surg. Oncol., 32, 6858, 10.1245/s10434-025-17675-1 · DOI
  81. Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI · Paper page
  82. Yeh, 2023, Sleep characteristics and inflammatory markers in women with post-traumatic stress disorder, BMC Psychiatry, 23, 273, 10.1186/s12888-023-04765-1 · DOI
  83. Yirmiya, 2011, Immune modulation of learning, memory, neural plasticity and neurogenesis, Brain Behav. Immun., 25, 181, 10.1016/j.bbi.2010.10.015 · DOI · Paper page
  84. Yu, 2011, Development of short forms from the PROMIS sleep disturbance and sleep-related impairment item banks, Behav. Sleep Med., 10, 6, 10.1080/15402002.2012.636266 · DOI · Paper page
  85. Zahnd, 2017, Contextual effects and cancer outcomes in the United States: asystematic review of characteristics in multilevel analyses, Ann. Epidemiol., 27, 739, 10.1016/j.annepidem.2017.10.002 · DOI
  86. Zeng, 2020, Gender difference in the prevalence of insomnia: a meta-analysis of observational studies, Front. Psych., 11

Metadata

Authors
Tapp, Z. M., Beales, J. T., Yiadom, S. A., Sardesai, S. D., Williams, N. O., Gatti-Mays, M. E., Stover, D. G., Sudheendra, P. K., Dawson, E., Wesolowski, R., Andridge, R. R., & Pyter, L. M.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2027-02
Volume
140
Pages
107089
ISSN
0889-1591
DOI
10.1016/j.bbi.2026.107089
Cited by
0
References
10
Language
en
Licence
Funders
National Institutes of Health National Cancer Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-reported sleep disturbances during chemotherapy mediate circulating IL-1β effects on subjective cognitive decline in breast cancer patients. https://app.cochat.ai/papers/10.1016/j.bbi.2026.107089
The paper
Tapp, Z. M., Beales, J. T., Yiadom, S. A., Sardesai, S. D., Williams, N. O., Gatti-Mays, M. E., Stover, D. G., Sudheendra, P. K., Dawson, E., Wesolowski, R., Andridge, R. R., & Pyter, L. M. (2027). Self-reported sleep disturbances during chemotherapy mediate circulating IL-1β effects on subjective cognitive decline in breast cancer patients. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2026.107089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.